• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性硬脑膜下血肿的中脑膜动脉栓塞治疗:当前文献的综合回顾。

Middle Meningeal Artery Embolization in the Management of Chronic Subdural Hematoma: a Comprehensive Review of Current Literature.

机构信息

Department of Neurosurgery, Lenox Hill Hospital, New York, NY, USA.

City University of New York School of Medicine, New York, NY, USA.

出版信息

Curr Neurol Neurosci Rep. 2023 Apr;23(4):109-119. doi: 10.1007/s11910-023-01262-6. Epub 2023 Apr 11.

DOI:10.1007/s11910-023-01262-6
PMID:37037979
Abstract

PURPOSE OF REVIEW

Chronic subdural hematoma (cSDH) is a common intracranial hemorrhagic disorder with a high incidence rate among the elderly. While small, asymptomatic cSDH may resolve spontaneously, surgical intervention has been the treatment of choice for larger, symptomatic cases. Surgical evacuation of cSDH may be associated with high rates of recurrence, and even asymptomatic cSDH cases tend to progress. Over the last few years, middle meningeal artery (MMA) embolization has proven to be a safe non-invasive treatment of choice with favorable outcomes and a low recurrence rate. The ensuing paper discusses current treatment modalities for cSDH and reviews existing literature on the anatomy of MMA and its embolization as a treatment option for cSDH.

RECENT FINDINGS

Recent studies show that traumatic head injury leading to subdural hemorrhage can induce neovascularization that may initiate a cycle of recurrent subdural hematoma. Distal branches of MMA supply blood to the dural layers. Several studies have revealed that embolization of the MMA can stop the neovascularization process and blood flow. In addition, patients who underwent MMA embolization had a significantly quicker brain re-expansion and lower recurrence rate. Although the management of cSDH is still very much a dilemma, recent research findings bring MMA embolization to light as a promising treatment alternative and adjunctive therapy.

摘要

目的综述

慢性硬脑膜下血肿(cSDH)是一种常见的颅内出血性疾病,在老年人中的发病率较高。小的无症状 cSDH 可能会自行消退,但对于较大的有症状病例,手术干预一直是首选治疗方法。cSDH 的手术清除可能与较高的复发率相关,甚至无症状的 cSDH 病例也往往会进展。在过去几年中,脑膜中动脉(MMA)栓塞已被证明是一种安全的非侵入性治疗选择,具有良好的疗效和较低的复发率。随后的论文讨论了 cSDH 的当前治疗方法,并回顾了 MMA 的解剖结构及其作为 cSDH 治疗选择的现有文献。

最新发现

最近的研究表明,创伤性头部损伤导致的硬脑膜下出血可诱导新生血管形成,从而引发复发性硬脑膜下血肿的循环。MMA 的远端分支为硬脑膜层供血。几项研究表明,MMA 栓塞可以阻止新生血管形成过程和血流。此外,接受 MMA 栓塞治疗的患者脑复张更快,复发率更低。尽管 cSDH 的管理仍然存在很大的困境,但最近的研究结果表明,MMA 栓塞作为一种有前途的治疗选择和辅助治疗方法受到关注。

相似文献

1
Middle Meningeal Artery Embolization in the Management of Chronic Subdural Hematoma: a Comprehensive Review of Current Literature.慢性硬脑膜下血肿的中脑膜动脉栓塞治疗:当前文献的综合回顾。
Curr Neurol Neurosci Rep. 2023 Apr;23(4):109-119. doi: 10.1007/s11910-023-01262-6. Epub 2023 Apr 11.
2
Subdural evacuation port system and middle meningeal artery embolization for chronic subdural hematoma: a multicenter experience.慢性硬脑膜下血肿的硬脑膜下引流管系统和脑膜中动脉栓塞治疗:多中心经验。
J Neurosurg. 2022 Nov 11;139(1):131-138. doi: 10.3171/2022.10.JNS221476. Print 2023 Jul 1.
3
Chronic subdural hematoma recurrence due to contralateral neovascularization following middle meningeal artery embolization.慢性硬脑膜下血肿复发,原因是中脑膜动脉栓塞后对侧新生血管形成。
Interv Neuroradiol. 2022 Dec;28(6):639-643. doi: 10.1177/15910199211065197. Epub 2021 Dec 13.
4
Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone.比较单纯颅骨钻孔引流术,颅骨钻孔引流联合或不联合中脑膜动脉栓塞治疗慢性硬脑膜下血肿的疗效和中期结果。
J Neurointerv Surg. 2022 Mar;14(3):297-300. doi: 10.1136/neurintsurg-2021-017450. Epub 2021 Jun 29.
5
Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption.脑膜中动脉栓塞术作为手术治疗症状性慢性硬脑膜下血肿的辅助治疗:一项评估血肿体积吸收的初步研究。
J Neurointerv Surg. 2020 Jul;12(7):695-699. doi: 10.1136/neurintsurg-2019-015421. Epub 2019 Dec 20.
6
Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases.老年非急性硬膜下血肿的脑膜中动脉栓塞治疗:151 例多机构经验。
Neurosurg Focus. 2020 Oct;49(4):E5. doi: 10.3171/2020.7.FOCUS20518.
7
Safety of Antithrombotic Resumption in Chronic Subdural Hematoma Patients with Middle Meningeal Artery Embolization: A Case Control Study.慢性硬膜下血肿患者行脑膜中动脉栓塞术后抗血栓治疗恢复的安全性:一项病例对照研究。
J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106318. doi: 10.1016/j.jstrokecerebrovasdis.2022.106318. Epub 2022 Feb 1.
8
Enhanced Hematoma Membrane on DynaCT Images During Middle Meningeal Artery Embolization for Persistently Recurrent Chronic Subdural Hematoma.在持续复发性慢性硬膜下血肿的脑膜中动脉栓塞术期间,DynaCT图像上增强的血肿膜
World Neurosurg. 2019 Jun;126:e473-e479. doi: 10.1016/j.wneu.2019.02.074. Epub 2019 Feb 28.
9
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations.慢性硬膜下血肿的脑膜中动脉栓塞术:154例连续栓塞的多中心经验
Neurosurgery. 2021 Jan 13;88(2):268-277. doi: 10.1093/neuros/nyaa379.
10
Middle Meningeal Artery Embolization of a Pediatric Patient With Progressive Chronic Subdural Hematoma.儿童进展性慢性硬膜下血肿的中间脑膜动脉栓塞术。
Oper Neurosurg (Hagerstown). 2021 Aug 16;21(3):E274-E277. doi: 10.1093/ons/opab144.

引用本文的文献

1
Surgical evacuation without versus with middle meningeal artery embolization in chronic subdural hematoma: A meta-analysis of randomized controlled trials.慢性硬膜下血肿手术清除术联合或不联合脑膜中动脉栓塞术:一项随机对照试验的荟萃分析
Neurol Sci. 2025 Jun 16. doi: 10.1007/s10072-025-08262-z.
2
Overcoming Challenging Vascular Anatomy in Chronic Subdural Hematoma: Direct Carotid Bulb Access and Contralateral Middle Meningeal Artery Embolization.克服慢性硬膜下血肿中具有挑战性的血管解剖结构:直接颈动脉球部入路和对侧脑膜中动脉栓塞术
J Neurol Surg Rep. 2025 May 27;86(2):e116-e121. doi: 10.1055/a-2603-9286. eCollection 2025 Apr.
3

本文引用的文献

1
Chronic Subdural Hematoma (cSDH): A review of the current state of the art.慢性硬膜下血肿(cSDH):当前技术水平综述
Brain Spine. 2021 Nov 2;1:100300. doi: 10.1016/j.bas.2021.100300. eCollection 2021.
2
Prognosis of patients with operated chronic subdural hematoma.手术治疗慢性硬脑膜下血肿患者的预后。
Sci Rep. 2022 Apr 29;12(1):7020. doi: 10.1038/s41598-022-10992-5.
3
Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives.
Efficacy and safety of middle meningeal artery embolization for nonacute subdural hematoma.
脑膜中动脉栓塞术治疗非急性硬膜下血肿的疗效与安全性
J Neurol. 2025 Apr 2;272(4):309. doi: 10.1007/s00415-025-13029-9.
4
Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH).基于多学科共识的关于脑膜中动脉栓塞术(MMAE)在慢性硬膜下血肿(cSDH)中当前作用的声明。
Brain Spine. 2024 Nov 19;4:104143. doi: 10.1016/j.bas.2024.104143. eCollection 2024.
5
Internal hematoma architecture predicts subdural hematoma responsiveness to standalone middle meningeal artery embolization.颅内血肿结构可预测硬膜下血肿对单纯脑膜中动脉栓塞术的反应性。
Neuroradiology. 2024 Dec;66(12):2261-2273. doi: 10.1007/s00234-024-03490-0. Epub 2024 Oct 18.
6
Effectiveness of traditional herbal Kampo medicine Goreisan on chronic subdural hematoma recurrence: a meta-analysis.传统草药汉方制剂桂枝茯苓丸对慢性硬膜下血肿复发的疗效:一项荟萃分析。
Front Pharmacol. 2024 Jul 15;15:1412190. doi: 10.3389/fphar.2024.1412190. eCollection 2024.
7
Predicting the progression of chronic subdural hematoma based on skull density.基于颅骨密度预测慢性硬膜下血肿的进展
Front Neurol. 2023 Oct 20;14:1279292. doi: 10.3389/fneur.2023.1279292. eCollection 2023.
慢性硬膜下血肿的脑膜中动脉栓塞术。一项聚焦于适应症、技术要点及未来可能前景的文献系统综述。
Surg Neurol Int. 2022 Mar 18;13:94. doi: 10.25259/SNI_911_2021. eCollection 2022.
4
The Middle Meningeal Artery: Branches, Dangerous Anastomoses, and Implications in Neurosurgery and Neuroendovascular Surgery.《中间脑膜动脉:分支、危险吻合及其在神经外科和神经介入血管外科中的意义》。
Oper Neurosurg (Hagerstown). 2022 Jan 1;22(1):1-13. doi: 10.1227/ONS.0000000000000010.
5
Expert consensus on drug treatment of chronic subdural hematoma.慢性硬膜下血肿药物治疗专家共识
Chin Neurosurg J. 2021 Nov 22;7(1):47. doi: 10.1186/s41016-021-00263-z.
6
Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases.阿托伐他汀联合小剂量地塞米松可能对白血病相关的慢性硬膜下血肿有效,但对白血病脑病无效:三例报告
Front Oncol. 2021 Jul 15;11:628927. doi: 10.3389/fonc.2021.628927. eCollection 2021.
7
Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.胶、玛瑙、乌贼还是 PHIL?用于栓塞脑动静脉畸形和硬脑膜动静脉瘘的液体栓塞剂。
Clin Neuroradiol. 2022 Mar;32(1):25-38. doi: 10.1007/s00062-021-01066-6. Epub 2021 Jul 29.
8
Middle Meningeal Artery Embolization Using Combined Particle Embolization and -BCA with the Dextrose 5% in Water Push Technique for Chronic Subdural Hematomas: A Prospective Safety and Feasibility Study.应用联合粒子栓塞和 -BCA 并结合 5%葡萄糖水推注技术行-middle 脑膜动脉栓塞治疗慢性硬脑膜下血肿:一项前瞻性安全性和可行性研究。
AJNR Am J Neuroradiol. 2021 May;42(5):916-920. doi: 10.3174/ajnr.A7077. Epub 2021 Mar 4.
9
Neuroanatomy of cranial dural vessels: implications for subdural hematoma embolization.颅脑膜血管的神经解剖:对硬膜下血肿栓塞的影响。
J Neurointerv Surg. 2021 May;13(5):471-477. doi: 10.1136/neurintsurg-2020-016798. Epub 2021 Feb 25.
10
Outpatient management of chronic expanding subdural hematomas with endovascular embolization to minimize inpatient admissions during the COVID-19 viral pandemic.在 COVID-19 病毒大流行期间,采用血管内栓塞术对慢性扩展型硬脑膜下血肿进行门诊管理,以尽量减少住院人数。
Interv Neuroradiol. 2021 Oct;27(5):716-721. doi: 10.1177/1591019921996510. Epub 2021 Feb 16.